Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 6/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.47 |
| ▸ | MGLL | Q99685 | 5/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1827335 | 0.98 | PTGS1 (0.46) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL7118902 | 0.93 | PTGS1 (0.42) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL13224224 | 0.89 | MGLL (0.54) | PTGS1PTGS2MGLLFAAHMAPT | |
| Trifluoroacetic Acid SCHEMBL19182964 | 0.88 | PTGS1 (0.42) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL20779330 | 0.87 | PTGS1 (0.43) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL15432729 | 0.87 | PTGS1 (0.61) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL2224805 | 0.85 | PTGS1 (0.64) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL1064498 | 0.85 | PTGS1 (0.64) | PTGS1PTGS2MGLLFAAHMAPT | |
| SCHEMBL25586124 | 0.85 | PTGS1 (0.64) | PTGS1PTGS2MGLLFAAHMAPT | |
| Hydrochloric Acid SCHEMBL1829332 | 0.84 | PTGS1 (0.62) | PTGS1PTGS2MGLLFAAHMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2026-02-12 | — | — | US | claimed |
| WO-2024103007-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| US-11975077-B2 | Guanylurea functionalized peptides and proteins for therapeutics | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-05-07 | — | — | US | claimed |
| CN-111505293-B | Test strip for detecting variegated aspergillin and application thereof | 北京望尔生物技术有限公司 | 2022-11-18 | — | — | CN | claimed |
| US-20220195072-A1 | TARGETED ANTICOAGULANT | NORTHWESTERN UNIVERSITY | 2022-06-23 | — | — | US | claimed |
| US-11332880-B2 | Modifying natural feathers for use in sporting goods | DURABIRD (US) | 2022-05-17 | — | — | US | claimed |
| US-20220001024-A1 | GUANYLUREA FUNCTIONALIZED PEPTIDES AND PROTEINS FOR THERAPEUTICS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-01-06 | — | — | US | claimed |
| US-20210214773-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2021-07-15 | — | — | US | claimed |
| CN-108136254-B | Natural feathers for use in sporting goods | 杜拉博德有限责任公司 | 2021-06-04 | — | — | CN | claimed |
| EP-3790544-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | The University of Chicago (US) | 2021-03-17 | — | — | EP | claimed |
| US-8420802-B2 | Polymer support | UNIVERSITY OF CAPE TOWN (ZA) | 2013-04-16 | — | — | US | claimed |
| EP-2478049-A1 | A POLYMER SUPPORT | University of Cape Town (ZA) | 2012-07-25 | — | — | EP | claimed |
| US-20120178916-A1 | Polymer Support | UNIVERSITY OF CAPE TOWN (ZA) | 2012-07-12 | — | — | US | claimed |
| WO-2011083360-A1 | A POLYMER SUPPORT | UNIVERSITY OF CAPE TOWN (ZA) | 2011-07-14 | — | — | WO | claimed |
| US-20110142762-A1 | Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent | NOVOZYMES BIOPHARMA DK A/S (DK) | 2011-06-16 | — | — | US | claimed |
| EP-1605979-B1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | UPPERTON LTD (GB) | 2008-10-22 | — | — | EP | claimed |
| JP-2006518727-A | — | — | 2006-08-17 | — | — | JP | claimed |
| US-20060171892-A1 | Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent | NOVOZYMES BIOPHARMA UK LIMITED (GB) | 2006-08-03 | — | — | US | claimed |
| EP-1605979-A1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | Upperton Limited (GB) | 2005-12-21 | — | — | EP | claimed |
| WO-2004071536-A1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | UPPERTON LIMITED (GB) | 2004-08-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975077-B2 | Guanylurea functionalized peptides and proteins for therapeutics | NPEPPS, SLC7A1, DNPEP | PTGS1 2746/4885PTGS2 2984/4885MGLL 2781/4885 |
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | RNMT, SMCHD1, PKLR | PTGS1 2240/4885PTGS2 2726/4885MGLL 1183/4885 |
| US-20220001024-A1 | GUANYLUREA FUNCTIONALIZED PEPTIDES AND PROTEINS FOR THERAPEUTICS | NPEPPS, SLC7A1, DNPEP | PTGS1 2703/4885PTGS2 3016/4885MGLL 2910/4885 |
| US-20210214773-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | RNMT, PHAX, RNGTT | PTGS1 2423/4885PTGS2 2935/4885MGLL 2208/4885 |
| US-20220195072-A1 | TARGETED ANTICOAGULANT | SERPINC1, PROC, PCSK6 | PTGS1 3759/4885PTGS2 3380/4885MGLL 3772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.